Test Price
2,800 AED✅ Home Collection Available
NDUFS1 Gene Mitochondrial Complex I Deficiency DNA Test in Dubai
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed Consultant Medical Geneticists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
This comprehensive genetic test for the NDUFS1 gene provides accurate diagnosis of mitochondrial complex I deficiency using next-generation sequencing (NGS) technology. The service includes mandatory pre-test genetic counselling, temperature-controlled cold-chain home collection, and secure post-result clinical guidance to ensure the highest standards of safety and data privacy under UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Test Overview & Methodology
The NDUFS1 gene encodes a core subunit of mitochondrial Complex I. Pathogenic variants cause progressive neurological deterioration known as mitochondrial complex I deficiency. This next-generation sequencing (NGS) analysis covers the full coding region to detect single nucleotide variants, small insertions/deletions, and copy number alterations, enabling accurate clinical diagnosis, carrier screening, and informed family planning.
| Feature | Our NDUFS1 NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Diagnostic Precision | 99.9% sensitivity for SNVs & indels | ~95% for targeted exons only |
| Methodology | Next-Generation Sequencing (Illumina) – full gene coverage | Sanger sequencing of select exons |
| Turnaround Time | 10–12 Business Days | 6–8 Weeks |
| Variant Detection | Deep intronic & copy number variants | Limited to known hotspots |
| Clinical Utility | Suitable for diagnosis, carrier testing & research | Primarily for familial mutation confirmation |
Physician Insight & Safety Protocols
"I recognise the profound implications of a genetic diagnosis for mitochondrial disorders. As a consultant in medical genetics, I emphasise that every NDUFS1 variant must be correlated with clinical presentation, neuroimaging, and biochemical markers before a final diagnosis is rendered. Comprehensive pre-test and post-test genetic counselling is essential to empower patients and families with a full understanding of inheritance patterns, recurrence risks, and available management strategies."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Safety Notice: Do not discontinue or alter any prescribed medication without consulting your treating physician. Genetic testing is an adjunct to, not a replacement for, ongoing clinical care.
Safety Exclusion Criteria
- Minors must be accompanied by a legal guardian and provide joint written consent in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Individuals unable to furnish a detailed clinical history and three-generation pedigree for accurate variant interpretation.
- Patients with an acute febrile illness or decompensated metabolic state at the time of sample collection.
Emergency Red Flags – Seek Immediate Medical Care If You Experience:
- New-onset seizures or loss of consciousness.
- Sudden severe muscle weakness or respiratory distress.
- Signs of metabolic acidosis: rapid breathing, intractable vomiting, confusion.
- Acute vision loss or stroke-like episodes.
Patient FAQ & Clinical Guidance
1. What is the NDUFS1 gene test and why is it performed?
The NDUFS1 genetic test is a next-generation sequencing analysis that identifies mutations causing mitochondrial complex I deficiency, a severe neurometabolic disorder. It helps confirm a clinical suspicion, guides treatment decisions, enables carrier testing for at-risk relatives, and provides prognostic information. Because the NDUFS1 gene encodes a critical enzyme subunit, detection of pathogenic variants allows precise genetic counselling and access to clinical trials.
2. How is the sample collected and what is the turnaround time?
A painless blood draw into an EDTA tube is collected at your home by a DHA-licensed phlebotomist, with results delivered within 10 to 12 business days. Our VIP mobile service operates from 8 AM to 11 PM daily, including weekends. Samples are transported in ISO-certified cold-chain containers to maintain DNA integrity. You will receive a secure online report and an optional tele-consultation to interpret findings.
3. Is this test covered by health insurance in the UAE?
We directly verify your insurance coverage with all major UAE insurers via WhatsApp; many plans cover genetic testing for clinically indicated neurological disorders. Upon receiving your insurance card image via WhatsApp at +971 54 548 8731, our billing team will confirm eligibility within one hour. Under UAE PDPL, your genetic data is handled with the highest confidentiality and never shared without explicit consent.
4. What does the pre-test genetic counselling involve?
Pre-test counselling is a mandatory consultation with our consultant medical geneticist to discuss the purpose, limitations, and potential implications of the test. This session covers inheritance patterns, recurrence risks, and the possibility of incidental findings. You will have the opportunity to ask questions and provide informed written consent before sample collection proceeds.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under the strict regulatory oversight of the Dubai Health Authority (DHA) and complies fully with all relevant UAE federal laws governing genetic testing, data protection, and healthcare practice.
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): All genetic and personal data is encrypted, access-controlled, and processed solely for diagnostic purposes. Data is never transferred to third parties without explicit patient consent.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: Electronic health records, tele-counselling platforms, and digital reporting systems comply with UAE cybersecurity standards for health data.
- Federal Decree-Law No. 4 of 2016 on Medical Liability: Patient safety, informed consent protocols, and clinical accountability are governed by this law, ensuring that all genetic testing is performed with full medical oversight and traceability.
Your genetic data remains strictly confidential and is retained only as required by UAE health record retention regulations. You retain the right to access, rectify, and request deletion of your personal data in accordance with PDPL provisions.
Clinical & Logistical Metadata
| Test Name | NDUFS1 Gene Mitochondrial Complex I Deficiency DNA Test |
| Price (AED) | 2,800 |
| Turnaround Time | 10–12 Business Days |
| Sample Type / Matrix | Peripheral Blood (EDTA Whole Blood) |
| Methodology Used | Next-Generation Sequencing (NGS) – Full Gene Coverage |
| ICD-10-CM Code | E88.49 |
| LOINC Code | 94222-8 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians